Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-10-31T17:27:06+0000
I'm a little template short and blank. I link to void and keep hidden out.
2024-10-31T17:27:06+0000
Sigma Healthcare faces regulatory hurdles and execution risks as it proposes a merger with Chemist Warehouse. Despite growth potential, valuations seem overly optimistic, leading to a sell rating.
2024-07-10T06:09:18+0100
Neuren stands out with the only FDA-approved treatment for Rett syndrome. With high margins, strong operating leverage, and a promising clinical pipeline, Neuren is poised for substantial growth.
2024-06-18T01:55:57+0100